PalinGen® Membrane is a human allograft processed from healthy amniotic tissue. PalinGen® Membrane provides a wound covering and support for native tissues. Just as the amniotic membrane acts as a physical barrier to cover and protect the fetus during pregnancy, PalinGen® Membrane provides a biological and physical overlay to support and protect the wound in vivo. Indicated for full and partial-thickness, acute, and chronic wounds.
Amniotic tissue and membrane are known to contain collagen substrates, growth factors and extracellular matrix proteins all recognized as part of the complex wound healing process. Amnio Technology products are derived exclusively from the amnion and are chorion-free. Key natural elements found in placental tissues:
Committed to a culture of Quality and continuous improvement, Amnio Technology has substantially invested in Processing/Manufacturing Operations. Employing state of the art manufacturing clean rooms, as well as closed aseptic isolator technology, ensures Products are processed in a manner that meets and exceeds Quality Standards as well as Regulatory expectations. By way of implementing semi-automated equipment and processes, Amnio Technology has developed a fully validated process which ensures Product Quality and consistency.
Amnio Technology is committed to Compliance, Quality and fosters a culture of Continuous Improvement. Amnio Technology has a core competency in Current Good Tissue Practices (cGTP). Our products meet or exceed the Quality and donor testing expectations set by the FDA in 21 CFR 1271. All Amnio Technology Products are manufactured in an FDA Registered and American Association of Tissue Banks (AATB) accredited facility.
An industry leader in the development and manufacture of amnion-derived technologies
Copyright © 2024 Amnio Technology, LLC